Luspatercept: A Review in Transfusion-Dependent Anaemia due to Myelodysplastic Syndromes or β-Thalassaemia.
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 945, doi. 10.1007/s40265-021-01527-9
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 8
Results: 9
1
2
Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 881, doi. 10.1007/s40265-021-01525-x
- By:
- Publication type:
- Article
3
Fostamatinib: A Review in Chronic Immune Thrombocytopenia.
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 935, doi. 10.1007/s40265-021-01524-y
- By:
- Publication type:
- Article
4
Ponesimod: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 957, doi. 10.1007/s40265-021-01523-z
- By:
- Publication type:
- Article
5
Melphalan Flufenamide (Melflufen): First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 963, doi. 10.1007/s40265-021-01522-0
- By:
- Publication type:
- Article
6
IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses.
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 895, doi. 10.1007/s40265-021-01521-1
- By:
- Publication type:
- Article
7
Fosdenopterin: First Approval.
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 953, doi. 10.1007/s40265-021-01520-2
- By:
- Publication type:
- Article
8
Targeting AMPK by Statins: A Potential Therapeutic Approach.
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 923, doi. 10.1007/s40265-021-01510-4
- By:
- Publication type:
- Article
9
Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review.
- Published in:
- Drugs, 2021, v. 81, n. 8, p. 907, doi. 10.1007/s40265-021-01505-1
- By:
- Publication type:
- Article